Mira Pharmaceuticals
€0.96
64
+€0+0% Oggi
Statistiche
In rialzo oggi
0.96
In ribasso oggi
0.96
In rialzo da 52 settimane
-
In ribasso da 52 settimane
-
Volume
0
Volume medio
-
Cap. di mercato
-
Rapporto P/E
-
Rendimento da dividendi
-
Dividendo
-
Prossimamente
Guadagni
27NovAtteso
EPS attesi
-0.13273510167
EPS effettivi
N/D
Le persone seguono anche
Questo elenco si basa sulle watchlist delle persone su Stock Events che seguono K6S.F. Non rappresenta una raccomandazione d'investimento.
Concorrenti
Questo elenco è un'analisi basata su recenti eventi di mercato. Non è una raccomandazione di investimento.
Info
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Show more...
CEO
Dipendenti
2
Paese
US
ISIN
US60458C1045
WKN
000A3EQWL